First-in-Human Safety, PK, and Food Effect Study of Single Ascending Doses of G1T38 in Healthy Volunteers

Summary

This first-in-human (FIH) study will provide the first safety and pharmacokinetic (PK) data for G1T38 in humans and will allow further development of G1T38 in patients with cancer.

Timeline

Start

2016-05

Primary completion

2016-12-15

Completion

2017-04-04

Drugs

Indications

No indication recorded.